Total Funding
19
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
133597
Mitralign is focused on developing a catheter-based technology for the percutaneous treatments of functional mitral regurgitation.
Acquired by 
Edwards Lifesciences
Richard Omilanowicz: COO and CFO
Adam Groothuis: Vice President
About the Company
Mitralign is a venture backed privately held company located in a suburb of Boston, MA. The company is developing an innovative catheter based technology for percutaneous treatment of functional mitral regurgitation. The novel Mitralign system emulates surgical annuloplasty as it delivers a series of surgical implants directly into the mitral
annulus by means of a catheter. The implants are cinched together, thus reducing the size of the mitral valve annulus and the valve opening.
Mitralign is funded by top tier venture capitalists and has two major cardiovascular device companies as investors.
